Scouring Genetic Variation within Our Cells for Drug Targets
Jacob Rubens, president of Quotient Therapeutics, discusses the company’s platform technology, how it uncovers genetic mutations at a cellular level, and its efforts to build a pipeline of therapies around the insights it gains.